keine Finanzberatung

ZTS · Zoetis Inc.

World's largest pure-play animal-health company (pet and livestock meds)

Risiko 4/10 · MODERATE RISK · derated pet-health leader · $75.81 ▼ 0.63%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $75.81
  • Market cap $31.3B
  • P/E (ttm) 12.37
  • Div yield 2.80%
  • 52-wk range $71.00 – $152.97
  • Index rank #118 / —

Wichtigste Risiken

  • Generic and rival competition against the Simparica and Apoquel franchises (Shareholders) — MED
  • Vet-visit and pet-spending slowdown (Shareholders) — MED
  • Pipeline fails to replace maturing blockbusters (Shareholders) — MED
  • Buyback-thinned equity magnifies the leverage optics (Bondholders) — LOW

Fazit

A great franchise at a broken-growth-stock price; the bet is that its dog drugs age more slowly than the market fears.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.